Can Weight-Loss Injections Like Ozempic and Mounjaro Reduce India’s Disease Burden?

Obesity is fast emerging as one of India’s biggest health challenges, driving diabetes, heart disease and other lifestyle disorders. As weight-loss injections like Ozempic, Mounjaro and Wegovy gain global attention, experts say these GLP-1 drugs can be powerful tools - but not a silver bullet. Scientifically proven to help tackle morbid obesity, they should be used under medical supervision and not as a quick fix, health leaders warn. Indiscriminate use and micro-dosing carry risks, but in the right hands, these treatments could significantly reduce the burden of non-communicable diseases. With patents nearing expiry and Indian companies working on affordable alternatives, wider access may soon be possible. If adopted responsibly, experts believe obesity control could fundamentally improve India’s health outcomes within the next few years.